WuXi PharmaTech (NYSE: WX) Names Temporary Chairman of the Audit...( SHANGHAI China Jan. 6 /Xinhua-- W...),Health

SHANGHAI, China, Jan. 6 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), China's premier provider of pharmaceutical R&D outsourcing services, announced today that Mr. Cuong Viet Do will temporarily assume the role of the Chairman of the Audit Committee until a permanent successor is appointed.

The Chairman of the Audit Committee was previously held by Mr. Shawn Wang who recently passed away in an accident during his vacation.

Mr. Cuong Viet Do has served as an independent director on WuXi PharmaTech's Board of Directors since July 2007 and is a member of the Audit Committee. Mr. Do is currently the chief strategy officer of Lenovo Group Limited. Mr. Do joined Lenovo in 2006 after 17 years at McKinsey & Company, where he was Director and senior partner. During his tenure at McKinsey, he consulted with leading companies in 18 countries and four continents on issues involving strategy, sales and marketing, operations, and corporate finance. Mr. Do was a leader of McKinsey's Corporate Finance practice and was responsible for training all of McKinsey's consultants on Finance and M&A topics. At different stages of his career at McKinsey, Mr. Do helped build and was a leader in the healthcare, high tech, and marketing practices. Mr. Do has more than a decade experience working with pharmaceutical and medical device companies around the world in R&D, sales and marketing, licensing & acquisitions, and operations. He has also served hospitals and governments on healthcare policy.

Mr. Do has a bachelor's degree in Biochemistry and Economics from Dartmouth College and a master's degree in Business Administration from the Tuck School of Business Administration, where he now serves on the MBA Board. He also serves on the boards of several non-profit groups, including Celebrate the Children, a school for autistic children, and the National Youth Science Foundation.

About WuXi PharmaTech

Founded in 2000, Shanghai-based WuXi PharmaTech is
'/>"/>